Display options
Cite
Elbadwi FA, Khairy EA, Alsamani FO, et al. Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Inform Med Unlocked. 2021;26:100725doi: 10.1016/j.imu.2021.100725.
Elbadwi, F. A., Khairy, E. A., Alsamani, F. O., Mahadi, M. A., Abdalrahman, S. E., Ahmed, Z. A. M., Elsayed, I., Ibraheem, W., & Alzain, A. A. (2021). Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Informatics in medicine unlocked, 26100725. https://doi.org/10.1016/j.imu.2021.100725
Elbadwi, Fatima A, et al. "Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies." Informatics in medicine unlocked vol. 26 (2021): 100725. doi: https://doi.org/10.1016/j.imu.2021.100725
Elbadwi FA, Khairy EA, Alsamani FO, Mahadi MA, Abdalrahman SE, Ahmed ZAM, Elsayed I, Ibraheem W, Alzain AA. Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies. Inform Med Unlocked. 2021;26:100725. doi: 10.1016/j.imu.2021.100725. Epub 2021 Sep 07. PMID: 34514079; PMCID: PMC8421083.
Copy Download .nbib Format: NLM
Share it on

Inform Med Unlocked. 2021;26:100725. doi: 10.1016/j.imu.2021.100725. Epub 2021 Sep 07.

Identification of novel transmembrane Protease Serine Type 2 drug candidates for COVID-19 using computational studies.

Informatics in medicine unlocked

Fatima A Elbadwi, Elaf A Khairy, Fatima O Alsamani, Mariam A Mahadi, Segood E Abdalrahman, Zain Alsharf M Ahmed, Inas Elsayed, Walaa Ibraheem, Abdulrahim A Alzain

Affiliations

  1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Gezira, Gezira, Sudan.
  2. Department of Pharmacology, Faculty of Pharmacy, University of Gezira, Gezira, Sudan.

PMID: 34514079 PMCID: PMC8421083 DOI: 10.1016/j.imu.2021.100725

Abstract

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emergence has resulted in a global health crisis. As a consequence, discovering an effective therapy that saves lives and slows the spread of the pandemic is a global concern currently.

© 2021 The Authors.

Keywords: COVID-19; Docking; Drug repurposing; Homology modeling; Molecular dynamics; TMPRSS2

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. N Engl J Med. 2020 Feb 20;382(8):727-733 - PubMed
  2. J Mol Graph Model. 2020 Nov;100:107697 - PubMed
  3. J Virol. 2011 May;85(9):4122-34 - PubMed
  4. Food Chem. 2021 Jun 1;346:128933 - PubMed
  5. Antiviral Res. 2015 Apr;116:76-84 - PubMed
  6. Comput Biol Med. 2021 Jan;128:104117 - PubMed
  7. Trends Microbiol. 2016 Jun;24(6):490-502 - PubMed
  8. Infect Genet Evol. 2020 Aug;82:104285 - PubMed
  9. Med Hypotheses. 2020 Nov;144:109984 - PubMed
  10. Cell. 2020 Apr 16;181(2):271-280.e8 - PubMed
  11. J Biomol Struct Dyn. 2021 Sep;39(15):5638-5656 - PubMed
  12. J Infect Public Health. 2021 May;14(5):611-619 - PubMed
  13. J Virol. 2014 Jan;88(2):1293-307 - PubMed
  14. Antimicrob Agents Chemother. 1979 Sep;16(3):362-5 - PubMed
  15. ACS Med Chem Lett. 2016 Dec 06;8(2):185-190 - PubMed
  16. Nat Rev Microbiol. 2021 Mar;19(3):155-170 - PubMed
  17. Microb Pathog. 2020 Dec;149:104546 - PubMed
  18. N Engl J Med. 2012 Nov 8;367(19):1814-20 - PubMed
  19. Eur J Clin Pharmacol. 2020 Dec;76(12):1623-1630 - PubMed
  20. J Antibiot (Tokyo). 1971 Jun;24(6):333-8 - PubMed
  21. Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7001-7003 - PubMed
  22. Int J Infect Dis. 2020 Sep;98:166-175 - PubMed
  23. Biomol Concepts. 2010 Oct;1(3-4):271-283 - PubMed
  24. Ann Anat. 2021 Mar;234:151657 - PubMed
  25. J Tradit Complement Med. 2021 Jun 3;: - PubMed
  26. Biochimie. 2017 Nov;142:1-10 - PubMed
  27. Hum Vaccin Immunother. 2020 Sep 1;16(9):2217-2218 - PubMed
  28. Parasitol Int. 2013 Dec;62(6):497-501 - PubMed
  29. Comput Biol Med. 2021 Aug;135:104555 - PubMed
  30. J Glob Antimicrob Resist. 2020 Sep;22:290-295 - PubMed
  31. Int J Biol Sci. 2020 Mar 15;16(10):1678-1685 - PubMed
  32. Clin Pharmacokinet. 2020 Jul;59(7):849-856 - PubMed
  33. J Virol. 2019 Mar 5;93(6): - PubMed
  34. J Microbiol Immunol Infect. 2018 Oct;51(5):636-643 - PubMed
  35. Phytomedicine. 2021 Oct;91:153704 - PubMed
  36. J Virol. 2013 May;87(10):5502-11 - PubMed
  37. Turk J Biol. 2020 Jun 21;44(3):185-191 - PubMed
  38. Front Chem. 2020 Aug 07;8:612 - PubMed

Publication Types